加藤浩司の業績
業績ページ.JPG

大学在籍中は臨床のみならず研究にも励んでおりました。また、2011年から2013年の2年間ボストン ハーバード大学マサチューセッツ総合病院に、 ポストドクトラルフェローとして在籍。研究発表は基礎研究から臨床研究まで多岐にわたっており、糖尿病患者、心筋梗塞患者、腎臓病患者、メタボリック症候群患者の冠動脈の特徴などを明らかにし、 実臨床に基づいた数多くの研究成果を挙げました。日本国内においても基幹病院と連携をとり臨床研究に参加することで得た膨大な知識により、“糖尿病、そして心臓と血管のスペシャリスト”としての地位を確立しています。

論文
論文学会発表は現行のページにさらに追加予定

1. Urotensin II activates sarcolemmal Na+/H+ exchanger in adult rat ventricular myocytes.

Kato K, et.al. J Cardiovasc Pharmacol. 2010 Feb;55(2):191-7

 

2. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study.

Kato K, et.al. JACC Cardiovasc Interv. 2012 Nov;5(11):1150-8.

 

3. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study.

Kato K, et.al. Circ Cardiovasc Imaging. 2012 Jul;5(4):433-40

 

4. Nonculprit coronary plaque characteristics of chronic kidney disease.

Kato K, et.al. Circ Cardiovasc Imaging. 2013 May 1;6(3):448-56.

 

5. Intracoronary imaging modalities for vulnerable plaques.

Kato K, et.al. J Nippon Med Sch. 2011;78(6):340-51. 

 

6. Marked improvement of extensive atelectasis by unilateral application of the RTX respirator in elderly patients.

Kato K, et.al. Intern Med. 2009;48(16):1419-23.

 

7. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization.

Kato K, et.al. Circ J. 2008 Sep;72(9):1499-505.

 

8. Mixed angina pectoris.

Kato K, Yasutake M. Nihon Rinsho. 2007 Sep 28;Suppl 5 Pt 2:117-20.

 

9. Combined therapy with percutaneous coronary intervention and percutaneous aortic valvuloplasty under mechanical support for an elderly patient with cardiogenic shock.

Kato K, et.al. J Nippon Med Sch. 2006 Jun;73(3):158-63.

 

10. Initial experiences of removal of intra-aortic balloon pumps with the Angio-Seal.

Kato K, et.al. J Invasive Cardiol. 2006 Mar;18(3):130-2.

 

11. Impact of Brain Natriuretic Peptide, Calcium Channel Blockers, and Body Mass Index on Recovery Time from Left Ventricular Systolic Dysfunction in Patients With Takotsubo Cardiomyopathy.

Shiomura R, Kato K, et al. Am J Cardiol. 2015 Aug 15;116(4):515-9.

 

12. Target lesion evaluation by multiple modalities in vivo: near-infrared spectroscopy (NIRS), virtual histology intravascular ultrasound, optical coherence tomography, and angioscopy.

Shibuya J, Kato K, et.al. EuroIntervention. 2015 Oct;11(6)

 

13. Superiority of the extracellular volume fraction over the myocardial T1 value for the assessment of myocardial fibrosis in patients with non-ischemic cardiomyopathy.

Inui K, Kato K, et.al. Magn Reson Imaging. 2016 Oct;34(8):1141-5

 

14. Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance.

Suzuki K, Kato K, et.al. PLoS One. 2016 Dec 9;11(12):0167645

 

15. Comparison by optical coherence tomography of the frequency of lipid coronary plaques in current smokers, former smokers, and nonsmokers.

Abtahian F, Kato K, et.al. Am J Cardiol. 2014 Sep 1;114(5):674-80.

 

16. Residual thrombus pattern in patients with ST-segment elevation myocardial infarction caused by plaque erosion versus plaque rupture after successful fibrinolysis: an optical coherence tomography study.

Hu S, Kato K, et.al. J Am Coll Cardiol. 2014 Apr 8;63(13):1336-8.

 

17. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.

Di Vito L, Kato K, et.al. Coron Artery Dis. 2014 Mar;25(2):172-85.

 

18. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study.

Vergallo R, Kato K, et.al. Am Heart J. 2014 Jan;167(1):59-67. 

 

19. Comparison of near-infrared spectroscopy and optical coherence tomography for detection of lipid.

Yonetsu T, Kato K, et.al. Catheter Cardiovasc Interv. 2014 Nov 1;84(5):710-7.

 

20. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.

Vergallo R, Kato K, et.al.  Am J Cardiol. 2013 Nov 1;112(9):1315-21.

 

21. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography.

Yonetsu T, Kato K, et.al. Circ Cardiovasc Imaging. 2013 Sep;6(5):665-73.

 

22. Optical coherence tomography– 15 years in cardiology.

Yonetsu T, Kato K, et.al. Circ J. 2013;77(8):1933-40. 

 

23. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography.

Jia H, Kato K, et.al. J Am Coll Cardiol. 2013 Nov 5;62(19):1748-58.

 

24. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study. Kim SJ, Kato K, et.al. Coron Artery Dis. 2013 Aug;24(5):431-9.

 

25. Ticagrelor immediately prior to stenting is associated with smaller residual thrombus in patients with acute coronary syndrome.

Abtahian F, Kato K, et.al. Int J Cardiol. 2013 Oct 3;168(3):3099-101.

 

26. Evaluation of culprit lesions by optical coherence tomography in patients with ST-elevation myocardial infarction.

Vergallo R, Kato K, et.al. Int J Cardiol. 2013 Sep 30;168(2):1592-3. 

 

27. Lipid rich plaque, female gender and proximal coronary stent edge dissections.

Zeglin-Sawczuk M, Kato K, et.al. J Thromb Thrombolysis. 2013;36(4):507-13. 

 

28. In vivo comparison of lumen dimensions measured by time domain-, and frequency domain-optical coherence tomography, and intravascular ultrasound.

Kim SJ, Kato K, et.al. Int J Cardiovasc Imaging. 2013 Jun;29(5):967-75. 

 

29. Clinical backgrounds and the time course of sleep-disordered breathing in patients after myocardial infarction.

Hayashi H, Kato K, et.al. J Nippon Med Sch. 2013;80(3):192-9

 

30. Reversible stenosis of the saphenous vein graft compressed by giant coronary aneurysm in Kawasaki disease.

Hosokawa Y, Kato K, et.al. J Am Coll Cardiol. 2013 Jul 9;62(2):e3. 

 

31. Prognostic value of depression, anxiety, and anger in hospitalized cardiovascular disease patients for predicting adverse cardiac outcomes.

Nakamura S, Kato K, et.al. Am J Cardiol. 2013 May 15;111(10):1432-6.

 

32. Reproducibility of in vivo measurements for fibrous cap thickness and lipid arc by OCT. Kim SJ, Kato K, et.al. JACC Cardiovasc Imaging. 2012 Oct;5(10):1072-4.

 

33. Significance of intraplaque neovascularisation for vulnerability: optical coherence tomography study.

Tian J, Kato K, et.al. Heart. 2012 Oct;98(20):1504-9. 

 

34. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.

Yonetsu T, Kato K, et.al. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):660-6.

 

35. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.

Yonetsu T, Kato K, et.al. Am J Cardiol. 2012 Oct 1;110(7):933-9.

 

36. Does neovascularization predict response to statin therapy? Optical coherence tomography study.

Tian J, Kato K, et.al. Int J Cardiol. 2012 Jul 26;158(3):469-70

 

37. Disruption of atherosclerotic neointima seven years after bare metal stent deployment.

Inami S, Kato K, et.al. Int Heart J. 2012;53(4):261-2.

 

38. Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina.

Kosugi M, Kato K, et.al. Circ J. 2011;75(9):2196-205. 

 

39. Angioscopic study of silent plaque disruption in nonischemic related coronary artery in patients with stable ischemic heart disease.

Wang Z, Kato K, et.al. Int Heart J 2010;51(6)383-7

 

40. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.

Tanaka K, Kato K, et.al. J Cardiol. 2010 Nov;56(3):291-9.

 

41. Solutions for retention of female cardiologists: from the survey of gender differences in the work and life of cardiologists.

Tsukada YT, Kato K, et.al.Circ J.2009;73(11):2076-83

 

42. Thrombolysis with a novel modified tissue-type plasminogen activator, monteplase, combined with catheter-based treatment for major pulmonary embolism.

Yamamoto T, Kato K, et.al. Circ J. 2009 Jan;73(1):106-10. 

 

43. Inappropriate analyses of automated external defibrillators used during in-hospital ventricular fibrillation.

Yamamoto T, Kato K, et.al. Circ J. 2008 Apr;72(4):679-81

 

44. Coronary perforation during percutaneous coronary intervention.

Shirakabe A, Kato K, et.al. Int Heart J. 2007 Jan;48(1):1-9.

 

45. Transient leukocytopenia associated with a steep surge of pro-inflammatory cytokines in a patient with severe cardiogenic pulmonary edema.

Yamamoto T, Kato K, et.al. Intern Med. 2006;45(20):1153-5.

 

46. Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance.Suzuki K, Kato K, et.al. PLos One. 2016;11(12):e00617-645

 

47. Superiority of the extracellular volume fraction over the myocardial T1 value for the assessment of myocardial fibrosis in patients with non-ischemic cardiomyopathy.

Inui K, Kato K, et.al. Magn Reson Imaging. 2016;34(8)1141-5

 

48. Impact of Brain Natriuretic Peptide, Calcium Channel Blockers, and Body Mass Index on Recovery Time from Left Ventricular Systolic Dysfunction in Patients WithTakotsubo Cardiomyopathy.

Shiomura R, Kato K, et.al. Am J Cardiol. 2015;116(4)515-9

 

49. Target lesion evaluation by multiple modalities in vivo: near-infrared spectroscopy (NIRS), virtual histology intravascular ultrasound, optical coherence tomography, and angioscopy.

Shibuya J, Kato K et.al. EuroIntervention 2015;11(6)

学会発表

国際学会

 

国際学会シンポジウム

OCT predictors of Stent Failure

Koji Kato, et. al . American College of Cardiology 2013. 3

 

国際学会一般講演

Non-Culprit Coronary Plaque Characteristics of Chronic Kidney Disease

Koji Kato, et. al  American College of Cardiology 2013.3

 

Coronary Plaque Characteristics in Diabetic Patients: Diabetic Status and Insulin Therapy

Koji Kato, et. al  American Heart Association 2012.11

 

Optical Coherence Tomography Findings Immediately After Single Stent Implantation in de novo Lesions and Their Clinical Significance

Koji Kato, et. al  American Heart Association 2012.11

 

Non-Culprit Plaques in Patients with Acute Coronary Syndrome (ACS) Have More Vulnerable Features Compared to Those with Non-ACS: A 3 Vessel OCT study

Koji Kato, et. al  American College of Cardiology 2012. 3

 

Coronary Plaque Characteristics in Diabetic Patients: A 3 vessel Optical CoherenceTomography study

Koji Kato, et. al  American College of Cardiology 2012. 3

 

Optical Coherence Tomography findings immediately post-stent implantation and their clinical significance

American College of Cardiology 2012. 3

Koji Kato, et. al

 

Human urotensin II activates sarcolemmal Na+/H+ exchanger: role of mitogen-activated protein kinases and protein kinase C

The 23nd European Section Meeting of International Society For Heart Research 2003.7

Koji Kato, et. al

 

Mitochondrial KATP channel opener, nicorandil, limits myocardial infarct size even when given during reperfusion alone

Koji Kato, et. al. The 22nd European Section Meeting of International Society For Heart Research 2002.6

 

 

 

国内学会

 

シンポジウム

Koji Kato. 

The Potential and Limitations of Optical Coherence Tomography (OCT) - From MGH OCT Registry-

第77回 日本循環器学会総会 2013年3月

加藤浩司他

集中治療チームで考えよう 集中治療での循環モニター 集中治療における心エコー検査の役割

第33回 日本集中治療学会総会 2006年3月

加藤浩司他

~ACS治療のトランスレーショナルリサーチ ―ニューデバイスから再生医療まで-~

心筋梗塞研究会 2005年7月

 

一般講演

加藤浩司他

糖尿病重症度とインスリン使用による冠動脈プラークの特徴~光干渉断層法(OCT)による検討

第57回 日本糖尿病学会総会 2014年5月

加藤浩司他

長期に及ぶ右心不全の原因がCABG術で使用した止血用シート剤による心外圧迫・収縮性心膜炎であった一例

第210回 循環器学会関東甲信越地方会 2008年12月

加藤浩司他  

高齢者喀痰喀出困難に伴う無気肺に対してRTXレスピレーターを用いた片側性陽陰圧体外式人工呼吸が有効であった二症例

第17回 日本集中治療学会関東甲信越地方会 2008年8月

加藤浩司他

II型解離へのhemiarch置換後にIIIb解離を発症、再々解離に対してステントグラフト治療が有効であった一例 

第205回 日本循環器学会関東甲信越地方会 2007年9月

加藤浩司他

閉塞性肥大型心筋症による重症急性循環不全に対して急性期心房同期心室ペーシングを行い救命できた二症例

第34回 集中治療学会総会 2007年3月

加藤浩司他

軽度腎障害患者の造影剤腎症に対するシスタチンCの有用性

第54回 日本心臓病学会 2006年9月

 

 

加藤浩司他

心嚢液貯留で発見された心臓血管肉腫に対して、放射線療法、免疫療法が著効し経過良好な一例

第200回 日本循環器学会関東甲信越地方会 2006年6月

加藤浩司他

急性心筋梗塞と大動脈弁狭窄症による心原性ショックに対して積極的治療によりショック離脱可能であった一例

第197回 日本循環器学会関東甲信越地方会 2005年10月

Koji Kato et.al.

Safety and Efficacy of Angio- Seal in removal of intra-aortic balloon pumps~A pilot study~

CCT2005 in Kobe 2005年9月

Koji Kato et. al

Human urotensin II activates sarcolemmal Na+/H+ exchanger: role of mitogen-activated protein kinases and protein kinase C

第67回 日本循環器学会総会 2003年3月

Koji Kato,et. al.

Mitochondrial KATP channel opener, nicorandil, limits myocardial infarct size even when given during reperfusion alone

第66回 日本循環器学会総会  2002年4月

加藤浩司他

一過性QS patternを呈したtachycardia induced cardiomyopathyの一例

第490回 日本内科学会関東地方会 2001年5月

加藤浩司他

心筋炎、心内膜炎、脳炎を合併し、意識障害、DIC、心室頻拍を呈したACTH単独欠損症の一例

第488回 日本内科学会関東地方会 2001年1月

加藤浩司他

冠動脈ステント留置術の長期成績:各種ステントにおける急性冠病変(ACS)と慢性冠狭窄(非ACS)との差違

第9回 インターベンション学会総会 2000年6月

加藤浩司他

二期的 PTSMA により安全に左室流出路および中流部閉塞の治療を施行した閉塞性肥大型心筋症(HOCM)の3例

第177回 日本循環器学会関東地方会 2000年12月

加藤浩司他

急性冠症候群の原因として推察されるいわゆるEmpty lipid pool像の自然経過を観察できた一例

第170回 日本循環器学会関東地方会 1999年3月